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Abstract.  Upon ligand binding, the 0/.6[3  4 integrin be- 
comes phosphorylated on tyrosine residues and com- 
bines sequentially with the adaptor molecules Shc and 
Grb2, linking to the ras pathway, and with cytoskeletal 
elements of hemidesmosomes. Since et6[34 is expressed 
in a variety of tissues regulated by the EGF receptor 
(EGFR), we have examined the effects of EGF on the 
cytoskeletal and signaling functions of O~6[~  4. Experi- 
ments of immunoblotting with anti-phosphotyrosine 
antibodies and immunoprecipitation followed by phos- 
phoamino acid analysis and phosphopeptide mapping 
showed that activation of the EGFR causes phosphory- 
lation of the 1~4 subunit at multiple tyrosine residues, 
and this event requires ligation of the integrin by lami- 
nins or specific antibodies. Immunoprecipitation exper- 
iments indicated that stimulation with EGF does not 
result in association of 0t6134 with Shc. In contrast, EGF 
can partially suppress the recruitment of Shc to ligated 
Ot6[~  4. Immunofluorescent  analysis revealed that EGF 
treatment does not induce increased assembly of 
hemidesmosomes, but instead causes a deterioration of 
these adhesive structures. Finally, Boyden chamber as- 
says indicated that exposure to EGF results in upregu- 
lation of a6134-mediated cell migration toward laminins. 
We conclude that EGF-dependent signals suppress the 
association of activated tX6~ 4 with both signaling and cy- 
toskeletal molecules, but upregulate et6134-dependent 
cell migration. The changes in 0t6134 function induced by 
EGF may play a role during wound healing and tumor- 
igenesis. 
T 
o  fully understand embryonic development, tissue 
repair, and tumor invasion, it is important to eluci- 
date the mechanisms by which growth factor- and 
integrin-dependent signals are integrated inside cells. It is 
known that integrins transmit positional cues from the ex- 
tracellular matrix to the cell interior, and the mechanisms 
by which these signals affect cellular responses  to growth 
and differentiation factors are being actively investigated 
(Juliano and Haskill, 1993; Giancotti and Mainiero, 1994; 
Schwartz et al., 1995). Conversely, growth factors and cy- 
tokines  can  modulate  a  number  of integrin-dependent 
functions, including cell adhesion (Serve  et al., 1995; Ki- 
nashi et al., 1995), cell migration (Chen et al., 1993; Mat- 
thay et al., 1993; Klemke et al., 1994), and cytoskeletal or- 
ganization (Ridley and Hall, 1992; Ridley et al., 1992), but 
the  mechanisms  underlying these  phenomena  are  less 
clear. 
The interaction between growth factor receptors and in- 
tegrins has been largely examined in fibroblasts  and plate- 
lets. Most of the studies have focused on the focal adhe- 
sion kinase p125  FAK (Schaller et al., 1992). In addition to 
being  activated and undergoing autophosphorylation in 
response to ligation of 131 and 133 integrins (Guan and Shal- 
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loway,  1992; Hanks  et  al.,  1992; Lipfert  et  al.,  1992), 
p125  FAK is the target of signals originating from a number 
of growth factors and mitogenic neuropeptides (Zachary 
and Rozengurt, 1992). The activation of p125  FAK has been 
linked to changes potentially important for the regulation 
of actin cytoskeleton, such as the phosphorylation of paxil- 
lin and tensin (Burridge et al., 1992; Bockholt and Bur- 
ridge,  1993) and the activation of Rho (McNamee et al., 
1992; Chong et al., 1994) and PI-3 kinase (Chen and Guan, 
1994). In addition, activated p125  FAK can combine with the 
Grb2/mSOS  complex potentially leading to stimulation of 
the ras-MAP (mitogen-activated protein) kinase pathway 
(Schlaepfer  et al., 1994), and insulin stimulation promotes 
association  of the etv133 integrin with the Insulin Receptor 
Substrate 1 and the Grb2/mSOS complex (Vuori and Ruo- 
slahti, 1994). These observations suggest that integrin- and 
growth factor-dependent signals may converge on p125  FAK 
and Insulin Receptor Substrate 1 to regulate gene expres- 
sion and the actin cytoskeleton. 
Much less is known about the integration of growth fac- 
tor- and integrin-dependent signals in epithelial and other 
cells that are in contact with the basement membrane. The 
~6134 integrin is expressed  in epithelial,  endothelial, and 
Schwann cells and binds to various  isoforms of the base- 
ment  membrane  component laminin  (Lee  et  al.,  1992; 
Niessen  et al., 1994; Spinardi  et al., 1995). Our previous 
studies have focused on the mechanisms by which this in- 
tegrin interacts with the cytoskeleton and with signaling 
molecules. In contrast to other integrins that localize to fo- 
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system,  1R6134 is found in hemidesmosomes in close proxim- 
ity to  molecules linking to  the  keratin  filament system 
(Carter et al., 1990; Stepp et al., 1990). There is evidence 
indicating that the association of 0L6134 with the hemides- 
mosomal cytoskeleton requires  the  uniquely large cyto- 
plasmic domain of [~4 and specifically a ~300-amino acid 
region, which includes the first two type III fibronectin- 
like modules and the connecting segment (Spinardi et al., 
1993). The ability of a tail-less mutant 134 subunit to pro- 
duce a dominant negative effect on the assembly of hemides- 
mosomes without suppressing cell adhesion to laminins in- 
dicates that Ot6134 plays an essential role in organizing the 
hemidesmosomal  cytoskeleton  (Spinardi  et  al.,  1995). 
Taken together, these observations suggest that laminin 
binding to 0~6134 promotes the nucleation of hemidesmo- 
somal cytoskeleton, and this activity is mediated by the 134 
cytoplasmic domain. 
Recent studies have indicated that ligation of the extra- 
cellular portion of 0t6134 causes tyrosine phosphorylation of 
the 134 subunit, and this event is mediated by protein ki- 
nase(s) physically associated with the integrin. Coimmu- 
noprecipitation experiments have shown that, upon liga- 
tion  of  the  extracellular  portion  of  0t6134  ,  the  adaptor 
protein Shc forms a complex with the tyrosine-phosphory- 
lated 134 subunit. Shc is then phosphorylated on tyrosine 
residues and recruits the adaptor protein Grb2, thereby 
potentially linking 0t6134 to the ras pathway. The 134 subunit 
is phosphorylated on multiple tyrosine residues in vivo, in- 
cluding a tyrosine-based activation motif (TAM) 1 resem- 
bling those found in the T cell and B cell receptors. Since 
phenylalanine substitutions at the 134 TAM disrupt the as- 
sociation of 0t6134 with hemidesmosomes, but do not inter- 
fere with tyrosine phosphorylation of Shc and recruitment 
of Grb2,  distinct sites  in  0~6134 mediate  assembly of the 
hemidesmosomal cytoskeleton and linkage to the ras path- 
way (Mainiero et al., 1995). 
The 0/.6[34 integrin is expressed in a variety of epithelial 
tissues that are regulated by the EGF (Sonnenberg et al., 
1990). In this study, we have examined the effects of EGF 
on the cytoskeletal and signaling functions of Ot6134. Our re- 
sults indicate that activation of the EGF receptor (EGFR) 
causes tyrosine phosphorylation of the 134 subunit, but this 
event is not followed by association of the integrin with 
Shc or by increased assembly of hemidesmosomes. In con- 
trast, EGF-dependent signals interfere with the ability of 
activated Ot6134 to associate with both signaling and cyto- 
skeletal molecules. Exposure to EGF causes deterioration 
of hemidesmosomes and leads to increased a6134-mediated 
cell migration toward laminins. 
Materials and Methods 
Cell Lines, Transfections, Antibodies, and ExtraceUular 
Matrix Molecules 
Human epidermoid carcinoma A431 cells were cultured in DME with 5% 
bovine FCS.  Mouse mammary RAC-11P/SD  cells (Sonnenberg et  al., 
1993)  and rat bladder 804G  cells (Izumi et al.,  1981)  were cultured in 
1. Abbreviations used in this paper: BPAG 2, bullous pemphigoid antigen 
2; EGFR, EGF receptor; MHC, major histocompatibility complex; TAM, 
tyrosine-based activation motif. 
DME with 10% FCS or bovine calf serum, respectively. Human primary 
keratinocytes  were  cultured  in  keratinocyte growth medium  (GIBCO 
BRL, Gaithersburg, MD). The 804G cells were cotransfected with the ex- 
pression vector pRK5-hEGF-R, encoding a full-length human EGFR (Ull- 
rich et al., 1984), and the hygromycin resistance plasmid pHBO by the cal- 
cium coprecipitation method (Giancotti  et  al.,  1994).  Stable cell lines 
expressing moderate levels of recombinant EGFR  (25-35  times lower 
than the endogenous EGFR in A431  cells) were selected by fluorescence 
activated cell sorting analysis and cultured with medium supplemented 
with 200  ixg/ml hygromycin (Calbiochem-Novabiochem Corp., La Jolla, 
CA). NIH-3T3 cells overexpressing a recombinant human EGFR (clone 
HER 14)  (Honegger et al.,  1987) were cultured in DME supplemented 
with 10% bovine calf serum and geneticin (GIBCO BRL). 
The mAb 3E1 reacting with the extracellular portion of human 134 and 
the rabbit polyclonal antiserum to the COOH-terminal peptide of 134 were 
described previously (Giancotti et al., 1992). The mAbs BV7 and TS2/16 
bind to the extracellular portion of the human [31 subunit (Martin-Padura 
et al., 1994; Arroyo et al., 1992). The rabbit antiserum to the cytoplasmic 
domain of av was previously described (Vogel et al.,  1993).  The anti- 
major histocompatibility complex (MHC) mAb W6.32 reacts with human 
and cultured rat cells (Kahn-Perles et al.,  1987).  The rabbit polyclonal 
anti-P-Tyr serum #72  was produced according to published procedures 
(Kamps and Sefton, 1988). The monoclonal anti-P-Tyr antibody 4G10 was 
obtained from UBI (Lake Placid, NY). The monoclonal anti-P-Tyr anti- 
body PY20 and the monoclonal anti-She antibody were from Transduc- 
tion Laboratories (Lexington, KY). The polyclonal anti-She serum #554 
was obtained by immunizing a rabbit with a glutathione-S-transferase fu- 
sion protein comprising the SH2 domain of the protein. The bullous Pem- 
phigoid antigen 2  (BPAG 2)-specific rabbit polyclonal antiserum was 
raised by immunization with a  glutathione-S-transferase fusion protein 
comprising the major antigenic determinant of the mouse protein in the 
laboratory  of Jouni  Uitto  (Thomas Jefferson University, Philadelphia, 
PA). The antiserum against the a5131 integrin purified from human pla- 
centa was generated in the laboratory of Erkki Ruoslahti (La Jolla Cancer 
Research Foundation, La Jolla, CA) as previously described (Argraves et 
al., 1986). This antiserum cross-reacts with rodent 131 integrins and blocks 
their function. The agarose-coupled 1G2 mAb was purchased from Onco- 
gene Science (Uniondale, NY). 
Human plasma fibronectin and human placental laminin 4 were pur- 
chased from GIBCO  BRL.  Laminin 5  matrices were prepared  as de- 
scribed previously (Sonnenberg et al., 1993; Spinardi et al., 1995). 
Biochemical Methods 
To test the effect of EGF on a6134, subconfluent A431  cells were serum 
starved and then treated with human recombinant EGF (Intergen Co., 
Purchase, NY). When indicated, the cells were detached by 10 mM EDTA 
and either kept in suspension or plated on dishes coated with extracellular 
matrix proteins before EGF stimulation. To examine the effect of selec- 
tive ligation of a6134, the cells were plated on fibronectin-eoated dishes, 
and then incubated with sulfate polystyrene latex beads coated with the 
3El or control mAbs TS2/16  and W6.32.  Stimulation of suspended cells 
with  antibody-coated  beads  was  performed  as  previously  described 
(Mainiero et al., 1995). At the end of incubation, the cells were extracted 
for 30 rain at 0°C with RIPA buffer (50 mM Tris, pH 7.5, 150 mM NaCI, 
0.5% Triton X-100, 0.5 % sodium deoxycolate, 0.1% sodium dodecyl sul- 
fate) or lysis buffer (50 mM Hepes, pH 7.5,  150 mM NaC1,  1% Triton 
X-100) containing I mM sodium orthovanadate, 50 mM sodium pyrophos- 
phate, 100 mM sodium fluoride, 0.01% aprotinin, 4 p.g/rnl pepstatin A, 10 
~g/ml leupeptin, 1 mM PMSF, 1 mM EDTA, and 1 mM EGTA (all from 
Sigma Chemical Co., St. Louis, MO). 
Immunopreeipitation and immunoblotting were performed as previ- 
ously described (Giancotti and Ruoslahti, 1990; Giancotti et al., 1992). Ni- 
trocellulose-bound antibodies were detected by chemiluminescence with 
ECL (Amersham Life Sciences, Little Chalfont, UK). 
Phosphopeptide mapping was performed essentially as described by 
Boyle et al.  (1991).  Serum-starved cells were labeled metabolically with 
[32p]orthophosphate (3 mCi/ml; ICN Biochemicals, Inc., Irvine, CA) for 3 h 
and then either treated with 250 ng/ml EGF for 5 min at 37°C or with 500 
I~M sodium orthovanadate and 3 mM H202 for 10 min at 37°C. After im- 
munoprecipitation with the 3E1 antibody, the samples were transferred to 
nitrocellulose. The nitrocellulose fragments containing 134 were soaked in 
0.5% polyvinylpyrrolidone (PVP-360; Sigma Chemical Co.), 100 mM ace- 
tic acid at 37°C for 30 min. Complete digestion was achieved by incubating 
the bands in 200 ~1 of 50 mM phosphate buffer, pH 7.8, containing 25 Ixg 
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Freehold,  NJ)  for  48  h  at  37°C. The  samples were  separated  by  two- 
dimensional TLC. Separation in the first dimension was achieved by elec- 
trophoresis in pH 1.9 buffer (2.5% formic acid, 7.8% acetic acid) (1.5 kV, 
50 min) and in the second, by ascending chromatography in phospho chro- 
matography buffer (37.5% n-butanol, 25 % pyridin, 7.5 % acetic acid). 
Phosphoamino acid analysis was performed as described by Boyle et al. 
(1991). 32p-labeled 134 was eluted from fixed polyacrylamide gels and pre- 
cipitated  with  20%  TCA.  32p-labeled  peptides  were  scraped  off TLC 
plates, eluted in 20% acetonitrile and 0.08% trifluoroacetic acid, and lyo- 
philized. Both types of sample were subjected to acid hydrolysis in 6 N 
HCI at ll0°C for 1 h. Phosphoamino acids were separated by two-dimen- 
sional TLC: electrophoresis in pH 1.9 buffer for the first dimension (1.5 
kV, 40 min) and in pH 3.5 buffer (5% acetic acid, 0.5% pyridine) for the 
second dimension (1.5 kV, 30 min). Nonradioactive standards were de- 
tected by ninhydrin staining. 
Adhesion and Migration Assays 
Adhesion assays were performed essentially as previously described (Gian- 
cotti et al., 1985). Before the assay, the cells were serum starved and either 
treated with 100 ng/ml EGF for 5 min or left untreated. After detachment 
by incubation in 10 mM EDTA, they were washed and plated on extracel- 
lular matrix-coated plates in the presence of anti-131  serum at 1:50. The re- 
sults were quantitated as previously described (Giancotti et al., 1986). 
Cell migration assays were performed by using modified Boyden cham- 
bers containing porous (8-1xm)  polycarbonate  membranes (Nunc, Ros- 
kilde, Denmark). To measure migration toward fibronectin and laminin 4, 
the lower aspect of the membrane was coated with 10 i~g/ml of each extra- 
cellular matrix protein. To measure migration toward laminin 5,  RAC- 
llP/SD  cells were cultured on the lower  aspect of the filter, and their 
laminin 5-containing matrix was prepared as described previously (Son- 
nenberg et al., 1993;  Spinardi et al., 1995).  Cells (50,000)  were added to 
the upper chamber in 200 Ixl of serum-free DME supplemented with 1% 
ITS+ (Collaborative Research, New Bedford, MA). EGF (50 ng/ml) and 
PDGF (5 ng/ml) were placed in the lower migration chamber in 500 ~1 of 
the  same medium. When  indicated,  the  inhibitory  anti-131  serum was 
added at 1"50 final dilution. After 12 or 48 h  of incubation at 37°C, the 
cells  that  had  migrated  across  the  membrane  were  fixed  with  3% 
paraformaldehyde, stained with crystal violet, and counted. 
Immunofluorescence 
The 804G transfectants and primary human keratinocytes were cultured 
on glass coverslips, starved for ~24 h and then treated with EGF, PDGF, 
or left untreated. After extraction with PBS containing 0.2% Triton X-100 
for 5 min on ice, the cells were fixed with methanol and stained for 45 min 
with the various antibodies. The anti-134 cytoplasmic peptide rabbit serum 
was diluted 1:200. The anti-BPAG 2 IgGs were used at 25 p~g/ml, and the 
3E1 mAb was used at 5 p~g/ml. After extensive washing, the cells were in- 
cubated for 45  min with 0.5-1  I~g/ml affinity-purified FITC-conjugated 
goat anti-rabbit  or  anti-mouse IgGs (Molecular  Probes,  Inc.,  Eugene, 
OR). The coverslips were mounted in Citi-Fluor (Chemical Laboratory of 
the University of Kent, Canterbury, UK). Samples were examined with a 
fluorescent microscope (Axiophot; Carl Zeiss, Inc., Thornwood, NY). 
Results 
EGF-mediated Tyrosine Phosphorylation 
of the [34 Subunit 
To test the hypothesis of a potential link between the in- 
tracellular responses elicited by EGF and the function of 
Ot6~ 4 integrin, we examined if treatment with EGF could 
induce tyrosine phosphorylation of Ot6~ 4 in cultured epi- 
thelial cells. The human epidermoid carcinoma A431 cells, 
which  express  high  levels  of  the  EGFR,  were  serum 
starved and either left untreated or exposed to EGF. Im- 
munoprecipitation with the anti-134 mAb 3E1 followed by 
immunoblotting  with  anti-phosphotyrosine  (anti-P-Tyr) 
antibodies indicated that treatment with EGF causes sig- 
nificant tyrosine phosphorylation of the  [34 subunit,  sug- 
gesting that ~6134 is a direct or indirect target of the EGFR 
(Fig. 1 A). To explore the selectivity of the effect of EGF 
on [34 phosphorylation, we asked if exposure to the growth 
factor also caused tyrosine phosphorylation of 131 or et  v in- 
tegrins. We reasoned that this experiment would have pro- 
vided for a good control, as the cytoplasmic domains of 131, 
133, 135, and 136 contain a conserved sequence motif resem- 
bling  a  major  tyrosine  autophosphorylation  site  in  the 
EGFR (Hynes, 1992).  As shown in Fig. 1 A, immunopre- 
cipitation with the anti-131 mAb BV7 or an anti-tXv cyto- 
plasmic domain serum followed by immunoblotting with 
anti-P-Tyr antibodies showed that exposure to EGF does 
not induce tyrosine phosphorylation of ~31 or av containing 
integrins (Fig. 1 A). This result suggests that the effect of 
EGF on  134 phosphorylation is selective. Experiments of 
[32p]orthophosphate labeling and phosphoamino acid anal- 
ysis were performed to confirm the ability of EGF to in- 
duce tyrosine phosphorylation of 134. The results indicated 
that  the  134  subunit  is  constitutively phosphorylated on 
serine,  and  it becomes phosphorylated on tyrosine resi- 
dues in response to EGF treatment (Fig. 1 B). Taken to- 
gether, these  results  demonstrate  that  the  134 subunit  is 
phosphorylated on tyrosine residues in cells exposed to EGF. 
Immunoblotting  with  anti-phosphotyrosine  antibodies 
indicated that the phosphorylation of 134 induced by EGF 
is dose dependent. In A431 cells, we detected a significant 
level of 134 phosphorylation in response to as little as 10 ng/ 
ml EGF, and maximal phosphorylation in response to 250 
ng/ml EGF (Fig. 2 A). The results of time course experi- 
ments indicated that the phosphorylation of 134 induced by 
EGF in A431  cells follows a  biphasic kinetics character- 
ized by a first rapid peak occurring at 2 min and a second 
one at ~120 min from the initial challenge (Fig. 2 B). The 
decline in 134 phosphorylation observed at 4 and 8 min af- 
ter the initial stimulus may be related to the internaliza- 
tion of EGF receptor, a phenomenon that occurs rapidly 
after ligand binding (Beguinot et al., 1984). This interpre- 
tation  is  supported  by the  observation  that  the  second 
peak of 134 phosphorylation induced by EGF occurs at a 
time when the downregulation of the EGF receptor has al- 
ready subsided (Teslenko et al.,  1987). The stoichiometry 
of  EGF-induced  134  phosphorylation  was  estimated  in 
A431 cells treated for 20 min with 50 ng/ml EGF. After ex- 
traction,  the  tyrosine-phosphorylated integrin was  sepa- 
rated from the nonphosphorylated one by affinity chroma- 
tography on the anti-P-Tyr mAb 1G2, and both fractions 
were subjected to immunoblotting with anti-134 antibodies 
(not  shown).  Densitometric analysis  of the  results  indi- 
cated that 83%  of the total [34 subunit had bound to the 
anti-phosphotyrosine affinity column. From these experi- 
ments, we concluded that the tyrosine phosphorylation of 
[34 induced by EGF in A431 cells is rapid, dose dependent, 
and characterized by a high stoichiometry. 
We next wondered if treatment with EGF caused ty- 
rosine phosphorylation of [34 also in normal epithelial cells, 
which express lower levels of the EGFR than A431 cells. 
As shown in Fig. 2 C (left), treatment of primary human 
keratinocytes with  10  ng/ml  EGF caused  significant ty- 
rosine phosphorylation of the [34 subunit. A  similar result 
was  obtained  with  rat  epithelial  804G  cells  expressing 
moderate levels of recombinant human EGFR (35 times 
lower than the endogenous EGFR in A431 cells) (Fig. 2 C, 
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rosine  phosphorylation  of 
the  [~4  subunit.  (A)  A431 
cells were serum starved and 
either left untreated or stim- 
ulated  with  250  ng/ml  EGF 
for 20 min. The samples were 
immunoprecipitated  with 
control  rabbit  anti-mouse 
IgGs,  anti-human  134  mAb 
3El,  anti-human  131  mAb 
BV7,  or  anti-et  v cytoplasmic 
domain  serum,  and  then 
probed  by  immunoblotting 
with  polyclonal  anti-P-Tyr 
antibodies.  (B)  A431 cells 
were  serum  starved,  meta- 
bolically labeled with [32p]or- 
thophosphate,  and  then  ei- 
ther  left  untreated  or 
stimulated  with  250  ng/ml 
EGF for 20 min. The samples 
were  immunoprecipitated 
with  control  rabbit  anti- 
mouse  IgGs  or  anti-human 
134 mAb 3El. The radioactive 
bands  corresponding  to  134 
were  subjected  to  phospho- 
amino acid analysis. 
right).  These results  indicate  that  EGF induces  tyrosine 
phosphorylation of 134 in cells that express moderate levels 
of EGFR, including primary epithelial cells. 
To explore the mechanism by which the EGFR induces 
tyrosine phosphorylation of the  134 subunit,  we examined 
the ability of immunopurified EGFR to phosphorylate in 
vitro the Ot6~  4 integrin or fusion proteins reproducing the 
134 cytoplasmic domain. Despite undergoing significant au- 
tophosphorylation,  the  EGFR  only  weakly  phosphory- 
lated  these  potential substrates  in  in  vitro assay (unpub- 
lished results). We also wondered if the EGFR and  0t6134 
stably interacted in A431 cells, but coimmunoprecipitation 
experiments performed under  mild detergent  conditions 
failed to demonstrate a specific association of the two mol- 
ecules (unpublished results). Although not conclusive, the 
results  of these  experiments  are  consistent  with  the  hy- 
pothesis that in vivo the EGFR does not directly phospho- 
rylate  134, but  rather  activates  a  signaling  pathway  that 
causes its phosphorylation. 
E G  F-mediated Tyrosine Phosphorylation o  f fl  4 Requires 
Ligation of the Integrin by ExtraceUular Matrix Ligands 
or Antibodies 
To examine if the ability of EGF to induce tyrosine phos- 
phorylation of 134 is influenced by cell adhesion, A431 cells 
were detached from the culture substratum, either kept in 
suspension or plated onto uncoated culture dishes for vari- 
ous times, and then treated with EGF. As shown in Fig. 3 
A, in the absence of EGF treatment, no tyrosine phosphor- 
ylation of 134 was detected  in both suspended  and  stably 
adherent cells. Treatment with EGF did not result in ty- 
rosine phosphorylation of 134 in  suspended  cells.  In con- 
trast,  the  growth factor induced  significant phosphoryla- 
tion of 134 in cells that had been plated on the culture dish 
for t>4 h and were stably adherent. The ability of EGF to 
induce tyrosine phosphorylation of 134 did not depend on 
cell-to-cell  contact,  as  sparse  and  confluent  cells  were 
equally susceptible to the effect of the growth factor. Im- 
munofluorescence  experiments  indicated  that  by 4  h  of 
plating the 0t6134 integrin had already redistributed  to the 
basal cell surface, presumably in response to extracellular 
matrix ligands deposited onto the culture substratum dur- 
ing adhesion (data not shown). These observations suggest 
a correlation between the recruitment of 0t6134 to the basal 
cell surface during adhesion and its susceptibility to EGF- 
mediated tyrosine phosphorylation. 
To examine the hypothesis that the tyrosine phosphory- 
lation of 134 induced by EGF requires ligation of the inte- 
grin by extracellular matrix ligand, A431 cells were plated 
on dishes coated with the 0t6134 ligands laminin 5 and lami- 
nin 4  or the  control  ligand  fibronectin, and  then  treated 
with EGF. Coating concentrations were adjusted so as to 
obtain the same extent of cell adhesion and spreading at 
30 min. As shown in Fig. 3 B, plating of the cells on lami- 
nin  5  and 4  rendered  the  134 subunit  fully susceptible  to 
EGF-mediated phosphorylation. In contrast, plating on fi- 
bronectin had a more modest effect. The effect of EGF on 
134 phosphorylation was maximal during initial adhesion to 
laminins and then declined. In accordance with the obser- 
vation that A431 cells adhere with a faster kinetics to lami- 
nin 5 than to laminin 4, the peak of 134 phosphorylation oc- 
curred  earlier  on  laminin  5  than  on  laminin  4.  Plating 
A431 cells onto laminin 5 in the absence of EGF also in- 
duced tyrosine phosphorylation of 134, but this phosphory- 
lation was of lower level and occurred with a slower kinet- 
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rosine  phosphorylation  of  134. Serum-starved  A431  cells  were 
treated for 20 min with the indicated concentrations of EGF (A), 
or treated with 50 ng/ml EGF for the indicated times (B). After 
immunoprecipitation  with  the  3El  mAb,  the  samples  were 
probed by immunoblotting with polyclonal anti-P-Tyr or anti-134 
cytoplasmic domain antibodies.  Growth factor-starved primary 
human keratinocytes (C, left) and 804G cells expressing a recom- 
binant EGFR (C, right) were treated with the indicated concen- 
trations of EGF for 15 min. Immunoprecipitation was with anti-134 
cytoplasmic domain antibodies  and  immunoblotting with  poly- 
clonal anti-P-Tyr antibodies. 
ics  than  in the  presence  of EGF  (Mainiero  et  al.,  1995). 
Control experiments revealed that the ability of EGFR to 
undergo  autophosphorylation,  as  well  as  to  induce  ty- 
rosine phosphorylation of several cellular substrates,  was 
similar in cells freshly plated on each one of the extracellu- 
lar matrix proteins tested, including fibronectin (Fig. 3 C). 
These  results  are  consistent  with  the  notion  that  ligand 
binding to 0t684 is required for optimal tyrosine phosphor- 
ylation of 84 in response to EGF stimulation. 
Since  the  A431  cells  express  at  least  another  integrin, 
ot381, capable of binding to laminin 5 and possibly to lami- 
nin 4, we wished to obtain direct evidence that ligation of 
Ot6134  at the cell surface is required for optimal phosphory- 
lation of 134. A431 cells were plated for 60 min on the con- 
trol  ligand  fibronectin,  and  then  incubated  for different 
times with polystyrene beads coated with the anti-84 mAb 
3El, the anti-81 mAb TS2/16, or the control anti-MHC mAb 
W6.32. As shown in Fig. 4, treatment with EGF caused sig- 
nificant tyrosine phosphorylation of 84 in cells exposed for 
10 min to the anti-84 beads, but not in cells treated  with 
anti-81  or anti-MHC  beads.  Incubation with  soluble  3El 
mAb produced a very modest effect. Control experiments 
indicated that treatment of A431 cells with anti-131 beads 
in the absence of EGF induces, as expected, a significant 
tyrosine  phosphorylation  of  p125 FAK  (data  not  shown). 
These  results  suggest  that  Ot6134  must  be  oligomerized  at 
the cell surface to be susceptible  to EGF-mediated phos- 
phorylation. 
Interestingly, while  EGF could consistently induce sig- 
nificant  tyrosine  phosphorylation  of  134 in  cells  that  had 
been plated  onto a  plastic  culture  substratum  for 4  h  or 
more (Fig. 3 A), maximal phosphorylation of 84 occurred 
only transiently in cells plated on laminin 5 and 4 (Fig. 3 B) 
or incubated with anti-134 beads (Fig. 4). The transient na- 
ture of the effect induced by initial ligation of 0/.684  on  ty- 
rosine phosphorylation of 84 may be explained by the pre- 
Figure 3.  EGF-mediated  ty- 
rosine phosphorylation of 134 
requires  extracellular  matrix 
ligand  binding.  (A)  A431 
cells  were  detached,  resus- 
pended  in  complete  me- 
dium, and either kept in sus- 
pension  or  replated  at  low 
density onto uncoated dishes 
for  4  or  12  h.  Where  indi- 
cated  by  the  asterisk,  the 
cells were plated at high den- 
sity and  reached  confluence 
by 12 h. The cells were either 
left  untreated  or  stimulated 
with  250  ng/ml EGF  for 20 
min,  and  then  immunopre- 
cipitated with the 3El mAb. 
Samples were probed by im- 
munoblotting with polyclonal anti-P-Tyr antibodies. (B) A431 cells were serum starved, detached, and then replated in serum-free me- 
dium on dishes coated with laminin 5 matrix, 10 i~g/ml laminin 4, or 10 ~g/ml fibronectin for the indicated times. In all cases, the cells 
were treated with 50 ng/ml EGF for 5 min, and then immunoprecipitated with the 3El mAb. Samples were probed by immunoblotting 
with polyclonal anti-P-Tyr antibodies. (C) A431 cells were serum starved, detached, and then either kept in suspension or replated in 
serum-free medium on dishes coated with laminin 5 matrix, 10 ~g/ml laminin 4, or 10 Ixg/ml fibronectin for 30 min. In all cases, the cells 
were treated with 50 ng/ml EGF for 5 min. Total proteins were probed by immunoblotting with polyclonal anti-P-Tyr antibodies. 
Mainiero et al. Regulation of %~4 lntegrin by EGF  245 Figure 4.  EGF-mediated tyrosine phosphorylation of ~4 requires 
ligation of the integrin. A431 cells were serum starved, detached, 
replated in serum-free medium on dishes coated with 10 txg/ml  fi- 
bronectin for 60 min, and then incubated for the indicated times 
with beads coated with the anti-J34 mAb 3El, the anti-131 mAb 
TS2/16, or the control  anti-MHC mAb W6.32. In all cases, the 
cells were treated with 50 ng/ml EGF for 5 min, and then immu- 
noprecipitated  with the 3E1 mAb. The samples were probed by 
immunoblotting with polyclonal anti-P-Tyr antibodies. 
vious observation that  tyrosine phosphorylation of  [34 is 
negatively regulated by tyrosine phosphatases  (Mainiero 
et al., 1995). Thus, although ligation of O~6134  can activate a 
tyrosine  kinase  responsible  for  [34  phosphorylation  and 
synergize with the effect of EGF, the subsequent activa- 
tion of tyrosine phosphatases able to reverse the phosphor- 
ylation of  [34  is  likely to  antagonize  the  effect of EGF. 
Taken  together,  these  results  suggest  that  clustering  of 
0t6134 induced by extracellular matrix ligands is required for 
optimal phosphorylation of the  [34 subunit in response to 
EGF stimulation. They further suggest that, depending on 
the timing, ligand binding to 0t6134 can  either synergize or 
antagonize with  a  signal  from the  EGFR  to  induce  ty- 
rosine phosphorylation of [34. 
EGF Induces Phosphorylation of  Multiple [34 
Tyrosine Residues 
Phosphopeptide mapping experiments were performed to 
analyze the  [34 sites phosphorylated in response to EGF 
treatment.  Since  cross-linking  of  0t6134  by  antibodies  or 
plating  on  laminin  5  did  not  induce  a  level of tyrosine 
phosphorylation of [34 sufficient for high resolution map- 
ping,  the sites phosphorylated in response to EGF were 
compared to those phosphorylated in response to pervan- 
adate.  Previous results  have  shown  that  treatment  with 
pervanadate results in phosphorylation of multiple [34 resi- 
dues, including the  [34 TAM and presumably also the Shc 
binding sites, since pervanadate can induce association of 
56[34 with Shc (Mainiero et al., 1995). A431 cells were met- 
abolically labeled with [32p]orthophosphate, and then ei- 
ther left untreated or stimulated with EGF or pervanadate. 
After immunoprecipitation, the [34 subunit was digested with 
Staphylococcus V8  protease,  and  the  resulting  peptides 
were separated by bidimensional TLC. As shown in Fig. 5 
A, the [34 subunit from unstimulated cells was resolved in a 
number of phosphopeptides (S1-S10). In accordance with 
the observation that [34 is phosphorylated constitutively on 
serine residues (Fig. 5 B), phosphoamino acid analysis in- 
dicated that these peptides contained only phosphoserine. 
Treatment with EGF resulted in the appearance of a num- 
ber of additional phosphopeptides (Y1-Y8) (Fig. 5 B), and 
phosphoamino acid analysis of several of them (Y1-Y6) 
confirmed  that  they  contained  exclusively  phosphoty- 
rosine. These results indicate that exposure to EGF results 
in phosphorylation of multiple tyrosine residues in the  ~4 
cytoplasmic domain. The phosphopeptide map of [34 from 
pervanadate-treated cells was similar, but not identical, to 
that of [34 from EGF-stimulated cells. It contained the pep- 
tides S1-S10 and Y1-Y8, but also an additional phospho- 
tyrosine-containing peptide, Y9. Furthermore, the inten- 
sity of the spot corresponding to phosphopeptide Y1 was 
much larger in pervanadate than in EGF-treated cells, and 
conversely, phosphopeptide Y6 was more intensely labeled 
in EGF than in pervanadate-treated cells (Fig. 5 C). Previ- 
ous  experiments of site-directed mutagenesis  and  phos- 
phopeptide mapping of [34 from pervanadate-treated cells 
have indicated that peptide Y5 contains tyrosine 1440, the 
COOH-terminal element of the TAM, and have provided 
circumstantial evidence that peptide Y2 contains tyrosine 
1422, the NH2-terminal element of the TAM (Mainiero et 
al.,  1995).  Since exposure to EGF resulted in the appear- 
ance of phosphopeptides Y5  and Y2, we concluded that 
EGF induces the phosphorylation of multiple tyrosine res- 
idues in  [34 and  that  these  include the  COOH-terminal, 
and possibly the NH2-terminal, element of the TAM. 
EGF-mediated Tyrosine Phosphorylation of [34 Does 
Not Result in Recruitment of the Adaptor Proteins Shc 
and Grb2 
To examine if EGF-mediated tyrosine phosphorylation of 
[34 results in association of the adaptor protein Shc to 0t6134 , 
A431 cells were either incubated with anti-[34 beads in sus- 
pension or treated with EGF while adherent. The resulting 
extracts were immunoprecipitated with anti-[34 antibodies 
and probed by immunoblotting with anti-[34 and anti-Shc 
antibodies. As shown in Fig. 6 A, ligation of Ct6134 led to re- 
cruitment of Shc. In contrast, treatment with EGF did not 
result in association of this adaptor molecule to 0t6134. Im- 
munoprecipitation with  anti-Shc  antibodies  followed by 
immunoblotting with anti-[34 antibodies confirmed that EGF 
stimulation does not result in recruitment of She to  Ot6~  4 
(Fig.  6  B).  Control experiments indicated that  a  certain 
amount of the adaptor molecule remained available in the 
cytoplasm of EGF-treated cells (not shown; see also Fig. 6 
C).  The results  of these  experiments suggest  that  EGF 
does not induce phosphorylation of the Shc binding sites 
in [34  . 
The inability of EGF to induce association of Shc with 
the Ot6134 integrin raises the possibility that the EGFR and 
ot6134 may, when simultaneously ligated, compete for this 
adaptor molecule in vivo. To explore this possibility, we 
examined the effect of EGF on the recruitment of Shc to 
activated  a6134,  As shown in Fig. 6  C, the amount of Shc 
coimmunoprecipitated with 56[34  was  lower in cells stimu- 
lated with anti-[34 beads and EGF than in cells treated only 
with anti-[34 beads. The inhibitory effect of EGF was espe- 
cially evident in cells that had been incubated with anti-[34 
beads for 5 or 10 min, irrespective of whether the EGF was 
The Journal  of Cell Biology,  Volume 134, 1996  246 Figure 5.  Phosphorylation of multiple [~4 tyrosine residues in response to EGF. A431 cells were metabolically labeled with [32p]ortho- 
phosphate and left untreated (.4), stimulated with 250 ng/ml EGF for 5 rain (B), or with 500 p~M pervanadate for 10 rain (C). After im- 
munoprecipitation with the 3E1 mAb and separation by SDS-PAGE, the radioactive bands corresponding to [3  4 were subjected to V8 
protease digestion, and the resulting phosphopeptides were separated by bidimensional TLC. 
applied together with the beads or before the beads. In ad- 
dition to indicating that a  certain amount of Shc remains 
available  for binding to  Ot6~  4  in EGF-treated  cells,  these 
results indicate that the EGFR and 0t613  4 integrin compete 
Figure 6.  EGF interferes with the recruitment of Shc to ¢3t6[~  4. (A) 
A431 cells were serum starved and either incubated for 10 rain in 
suspension with polystyrene beads coated with the anti-134 mAb 
3E1 or treated for 5 min while  adherent with 200 ng/ml EGF. 
Control cells consisted of suspended cells  left untreated.  Equal 
amounts of total proteins were immunoprecipitated with anti-134 
cytoplasmic peptide serum and probed by immunoblotting with 
the same antiserum  (top) or anti-Shc mAb (bottom).  (B) A431 
cells were treated as above, but immunoprecipitated with anti- 
Shc polyclonal antibodies  and probed with either  anti-134 cyto- 
plasmic peptide serum (top) or the anti-P-Tyr mAb PY20 (bot- 
tom). (C) A431 cells were serum starved, detached and replated 
in serum-free medium on dishes coated with 10 p.g/ml fibronectin 
for 60 min. They were then incubated for the indicated times with 
3E1  mAb-coated  beads,  50  ng/ml  EGF,  or  3E1  mAb-coated 
beads  followed or preceded  by a  5-min exposure  to 50  ng/ml 
EGF. The extracts were immunoprecipitated with anti-134 cyto- 
plasmic peptide  antibody and probed by immunoblotting with 
anti-Shc mAb. 
for this adaptor molecule in cultured cells, raising the pos- 
sibility that the ability of ~6~4  to link to the  ras pathway 
may be suppressed by EGF-dependent signals in vivo. 
Disruption of Hemidesmosomes by EGF 
To examine the effect of EGF on the ability of ct6134 to as- 
sociate with the hemidesmosomal cytoskeleton, we elected 
to use  the  rat  804G  bladder  epithelial  cells,  which form 
hemidesmosomes  in vitro.  Since  these  cells  express  very 
low levels of the EGFR, we used cell lines expressing mod- 
erate  levels of human EGFR  from cDNA. Immunoblot- 
ting  analysis  of total  proteins  with  anti-P-Tyr  antibodies 
indicated  that exposure of the EGFR-transfected  cells to 
EGF resulted in tyrosine phosphorylation of the recombi- 
nant EGFR and of several of its cellular substrates, includ- 
ing the [3  4 subunit (data not shown and Fig. 2 C, right). 
The  EGFR-transfected  804G  cells  were  starved,  and 
then either left untreated or treated for various times with 
100 ng/ml EGF. Immunofluorescent analysis revealed that 
while in control cells, ~6134 and the BPAG 2 were concen- 
trated at the basal cell surface within Triton X-100-resistant, 
"Swiss cheese"-like  structures  corresponding to hemides- 
mosomes (Fig. 7, a and b); in cells treated with EGF, these 
molecules  had  undergone  a  profound redistribution  and 
were  no  longer  detected  in  association  with  these  struc- 
tures (Fig. 7, d and e). To confirm the physiological signifi- 
cance  of these  observations,  we  examined  the  effect  of 
EGF  on  the  hemidesmosome-like  structures  formed  by 
normal human primary keratinocytes in culture. As shown 
in Fig. 7 (c and f), treatment with EGF resulted in loss of 
hemidesmosomal  staining  also  in  these  cells,  suggesting 
that disassembly  of hemidesmosomes  may be  one of the 
physiological consequences of activation of the EGFR in 
primary  epithelial  cells.  Immunofluorescent  analysis  of 
EGFR  transfected  804G  cells  treated  for  various  times 
with EGF indicated that the effect of the growth factor on 
hemidesmosomes  was  already  significant  after  1  h  and 
Mainiero et al. Regulation of ct6fl  4  Integrin by EGF  247 Figure 7.  Disruption of hemidesmosomes by EGF. EGFR-transfected 804G cells (a, b, d, and e) and primary human keratinocytes (c 
and f) were cultured  on glass coverslips for 48 h, serum starved, and either left untreated (a--c) or treated with 100 ng/ml EGF for 12 h 
(d-f). After extraction with 0.2% Triton X-100, the cells were fixed and stained with anti-BPAG 2 antibodies  (a and d), anti-J34 cytoplas- 
mic peptide serum (b and e), or the antiq34 mAb 3El (c and f) followed by FITC-labeled afffinity-purified secondary antibodies. 
complete  by  12  h  of  treatment  (Fig.  8,  a-e).  Dose- 
dependency experiments indicated that 25 ng/ml of EGF 
were sufficient to induce a  significant effect on hemides- 
mosomes (data not shown). The effect of EGF was specific 
as  PDGF  did  not  cause  any change  in  hemidesmosome 
staining (Fig. 8 f). Similar results were obtained with three 
independent clones of EGFR-transfected 804G cells. These 
observations indicate  that EGF treatment  causes disrup- 
tion of hemidesmosomes. 
The ability of EGF to induce hemidesmosome disassem- 
bly was unexpected because phosphopeptide mapping had 
indicated  that  the  [34  TAM,  which  mediates  a  signaling 
event required for the  association of Ot6[~  4  with hemides- 
mosomes (Mainiero et al., 1995), is phosphorylated in re- 
sponse  to  EGF.  We  wondered  if the  effect of EGF  on 
hemidesmosomes was caused by its ability to downregu- 
late  ligand  binding  to  Ot6[~  4  by  a  mechanism  of inside- 
to-outside signaling. The effect of EGF treatment on the 
adhesion of EGFR-transfected 804G cells to laminin 4 and 
5 was therefore examined. To block  [31-dependent adhe- 
sion, the cells were plated on the two extracellular matrix 
proteins in  the  presence of inhibitory anti-J31 antibodies. 
As shown in Fig. 9, the extent to which the EGFR-trans- 
fected 804G cells adhered to laminin 4 and 5 was not sig- 
nificantly changed after treatment with EGF. A  similar re- 
sult  was  obtained  with  A431  cells  (not  shown).  These 
results indicate that exposure to EGF does not cause a sig- 
nificant change in ligand binding to  Ot6[~4, thus suggesting 
that  the  deterioration  of  hemidesmosomes  observed  in 
EGF-treated cells  is  not  caused  by a  downregulation  of 
ligand  binding.  Together with the  observation that  EGF 
induces phosphorylation of the  [~4 TAM, these data sug- 
gest the hypothesis that EGF-dependent signals suppress 
the association of OL6[~  4 with the hemidesmosomal cyto6kel- 
eton by interfering with the functioning of signaling and 
cytoskeletal molecules downstream of the [~4 TAM. 
Increased  a6~4-dependent Cell Migration in Response 
to EGF 
To  determine  if the  apparent  disruption  of hemidesmo- 
somes caused by EGF correlates with  a  change  in  ot6134- 
The Joufnal  of Cell Biology,  Volume 134, 1996  248 Figure 8.  Kinetics  and specificity of EGF-induced hemidesmosome disruption.  EGFR-transfected 804G cells were cultured  on glass 
coverslips for 48 h, serum starved, and either left untreated (a) or treated with 100 ng/ml EGF for 30 min (b), 1 h (c), 3 h (d), or 12 h (e). 
As a control, cells were exposed to 5 ng/ml PDGF for 12 h (f). After extraction with 0.2% Triton X-100, the cells were fixed and stained 
with anti-BPAG 2 antibodies followed by FITC-labeled affinity-purified secondary antibodies. 
dependent cell migration, we measured the ability of con- 
trol and EGFR-transfected 804G ceils to migrate toward 
various extracellular matrix components by using a  Boy- 
den chamber system. As shown in Fig. 10, treatment with 
EGF resulted in increased migration of the EGFR-trans- 
fected 804G cells toward the  two  et6134 ligands laminin 4 
and  5,  but  not  the  control ligand  fibronectin,  suggesting 
that  EGF-dependent  signals  can  increase  cell  migration 
toward  Ot6[~  4  ligands.  In  addition,  the  basal migration  of 
EGFR-transfected 804G cells toward laminin 4 and 5 was 
greater than that of control 804G cells. This result suggests 
that the recombinant EGFR may be partially active in the 
absence  of exogenous  ligand  in  804G  ceils,  perhaps be- 
cause these  cells secrete EGF or TGF-cx. In accordance 
with  this  hypothesis,  we  found  that  the  medium  condi- 
tioned  by 804G cells is capable of stimulating  the  auto- 
phosphorylation  of  recombinant  EGFR  expressed  in 
transfected 804G cells (data not shown). Inhibitory anti-131 
antibodies were able to suppress the migration of unstimu- 
lated cells toward laminin 5 by 91 +_ 6%, but only inhibited 
the migration of EGF-treated cells by 11 ___ 3%, indicating 
that the EGF-stimulated migration toward laminin 5 was 
largely dependent  on  ot6~  4 function.  This conclusion was 
also supported by the observation that EGFR-transfected 
NIH-3T3 fibroblasts, which  do not express  ot6134, did not 
respond to EGF with increased migration toward laminin 
4  (Fig.  10,  top).  Finally, the  effect of EGF was specific, 
since it was not observed in response to PDGF or with the 
control 804G cells in  response to EGF.  Taken together, 
these  results  indicate  that  EGF  specifically  upregulates 
et6~a-dependent migration toward laminins. 
Discussion 
Several observations suggest that ct6~  4- and growth factor- 
dependent signals may cooperate to control epidermal cell 
proliferation and migration. In stratified epithelia, such as 
the epidermis, 0~6134 mediates the interaction of basal kera- 
tinocytes  with  the  basement  membrane  (Kajiji  et  al., 
1989), and there is evidence indicating that these cells have 
to remain in contact with this extracellular matrix to main- 
tain  their  proliferative potential  (Green,  1977;  Hall  and 
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Figure 9.  EGF does  not  affect  ot6134-dependent cell  adhesion. 
EGFR-transfected 804G cells were starved and either left un- 
treated or stimulated  with 100 ng/ml EGF. The cells were plated 
in the presence of inhibitory  anti-J31 antibodies  on dishes coated 
with the indicated  amounts of laminin 4 for 60 min (top)  or on 
laminin 5 matrix-coated dishes for the indicated times (bottom). 
Watt,  1989).  Furthermore,  the  coincident  expression  of 
0t6134 and laminins by keratinocytes migrating into corneal 
wounds suggests a role for a6134-mediated  migration dur- 
ing the reepithelialion of wounds (Kurpakus et al., 1991). 
Prompted by the prominent role of EGF and transforming 
growth factor a  in controlling keratinocyte growth and mi- 
gration  (Rheinwald  and  Green,  1977;  Barrandon  and 
Green, 1987), and by the coincident expression of a6134 and 
EGFR in basal keratinocytes in vivo (Green et al., 1987; 
Kajiji et al., 1989),  we have examined the effect of EGFR 
activation on the intracellular functions  of Ot-61~  4.  Our re- 
suits indicate that EGF-dependent signals have a complex 
effect on  0t.6134 function: they cause tyrosine phosphoryla- 
tion of 134 without promoting the association of Shc, induce 
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Figure 10.  EGF stimulates  et6134-dependent cell migration.  The 
indicated  cell lines were allowed to migrate toward laminin 4 for 
48 h, laminin 5 for 12 h, and fibronectin for 48 h in the presence of 
control medium (open bars), 50 ng/ml EGF (closed bars), or 5 ng/ 
ml PDGF (hatched bars). 
disassembly of hemidesmosomes, and upregulate cell mi- 
gration on laminins. 
In this study, we provide direct evidence that activation 
of the  EGFR causes tyrosine phosphorylation  of the  134 
subunit.  This phosphorylation is characterized by a rapid 
kinetics and, at least in A431 cells, by a high stoichiometry. 
Since  we  have been unable  to obtain  evidence that  the 
EGFR efficiently phosphorylate 134 in vitro, it is our hy- 
pothesis that the EGFR does not directly phosphorylate 
~4 in vivo, but rather it activates a signaling pathway that 
results in its phosphorylation. The observation that EGF- 
mediated phosphorylation of 134 requires ligation of the in- 
tegrin by extracellular ligand  or antibodies suggests that 
this phosphorylation event is mediated by an integrin-as- 
sociated kinase acting in trans. Future studies will be re- 
quired to determine if Ot6134 is indeed an indirect target of 
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kinases, one activated by EGF and the other by extracellu- 
lar matrix binding,  or with a  single tyrosine kinase  acti- 
vated by both stimuli. 
The results  of phosphopeptide  mapping  indicate  that 
EGF causes phosphorylation of several distinct [34 tyrosine 
residues. Although the majority of the tyrosine phospho- 
rylation sites in [34 remain to be identified and their func- 
tion assessed, the complexity of the tyrosine phosphoryla- 
tion  pattern  induced  by  EGF  suggests  that  many  O/.6~  4 
functions may be regulated by the growth factor. One ma- 
jor intracellular function of ~6[~4  that is negatively regu- 
lated by EGF is the recruitment of the adaptor molecule 
Shc. Treatment with EGF does not result in the associa- 
tion of 0t6134 with Shc and presumably Grb2. In fact, expo- 
sure to EGF partially suppresses the recruitment of Shc to 
the  ligated  integrin.  Although  it  is  possible  that  EGF 
causes  a  conformational change  or  another posttransla- 
tional modification of 0t6134 that prevents it from binding to 
Shc, the most likely explanation of these results is that the 
growth factor does not induce phosphorylation of the Shc 
binding motifs in 134. The observation that the EGFR can 
compete with 0~6134 for the recruitment of Shc is in accor- 
dance with the recognized ability of activated EGFR to as- 
sociate with  this  adaptor molecule (Pellicci et al.,  1992) 
and suggests that a significant activation of the EGFR may 
interfere with the ability of ligand-occupied Ot6134 to  acti- 
vate signaling in vivo. In contrast, when suboptimally li- 
gated, the EGFR and  et6134 are likely to cooperate with 
each other to activate the ras  pathway. This latter predic- 
tion may be relevant to understanding anchorage-depen- 
dent cell growth in epithelial cells. 
The results of our immunofiuorescent analysis indicate 
that treatment with EGF causes disruption of hemidesmo- 
somes in both EGFR-transfected 804G ceils and primary 
human  keratinocytes. What  is  the  mechanism  by which 
EGF interferes with the  assembly of hemidesmosomes? 
Our  previous  studies  suggest  that  the  nucleation  of 
hemidesmosomes  requires  a  signal  mediated  by  the  [34 
TAM (Mainiero et al., 1995). It is, however, unlikely that 
the phosphorylation of the TAM is the only Ot6~ 4 function 
necessary for the assembly of hemidesmosomes. Deletion 
mutagenesis experiments have indicated that the associa- 
tion of Ot6134 with the hemidesmosomal cytoskeleton not 
only requires the connecting segment, which includes the 
TAM, but also sequences within the two type III fibronec- 
tin-like  modules  upstream  of  the  connecting  segment 
(Spinardi,  L.,  and  F.G.  Giancotti,  unpublished  results). 
This observation is consistent with the hypothesis that a 
TAM-dependent signal renders one or more cytoskeletal 
elements  of hemidesmosomes competent for binding  to 
sequences  within  the  first  two  type  III  fibronectin-like 
modules of 134. Further assembly of hemidesmosomes may 
then be driven by the cooperative binding of additional cy- 
toskeletal elements. Based on this model, EGF-dependent 
signals  may interfere with  the  assembly of hemidesmo- 
somes at one or more of several steps. Since EGF does not 
affect et6134-mediated adhesion to laminins  and does not 
suppress phosphorylation of the [34 TAM, the growth fac- 
tor may interfere with the functioning of one or more sig- 
naling  or cytoskeletal molecules located  downstream  of 
the TAM in the pathway that controls the association of 
0t6134 with the cytoskeleton. Furthermore, it is possible that 
EGF induces the phosphorylation of tyrosine residues lo- 
cated within the first two type III fibronectin-like modules 
of the [34 tail, thus directly interfering with the association 
of  cytoskeletal  molecules.  Finally,  as  the  process  of 
hemidesmosome formation is likely to be complex and to 
require the function of many components in addition to 
Ot6[~  4 and the molecules to which it binds, EGF may disrupt 
hemidesmosomes by acting on one or more of these addi- 
tional components. 
Most of the previous studies on the regulation of the cy- 
toskeleton by growth factors have focused on the effects of 
EGF and PDGF on the actin filament system. It has been 
known for long that these growth factors can induce pro- 
found changes in the architecture of the actin cytoskeleton 
(Bockus and Stiles, 1984; Herman and Pledger, 1985). Re- 
cent studies have indicated that they can induce the se- 
quential formation of filopodia, lamellipodia, and focal ad- 
hesions, and that these cytoskeletal changes are mediated 
by  a  GTPase cascade  involving Cdc 42,  Rac,  and  Rho 
(Nobes and Hall, 1995). Our current observations clearly 
indicate that EGF can also profoundly affect the keratin 
filament system, thereby providing evidence for a  novel 
mechanism of cytoskeletal regulation by EGF. 
The changes in the association of 0t6134 with the cytoskel- 
eton induced by activated EGFR are likely to be signifi- 
cant  in  both  physiological  and  pathological  situations. 
Several lines of evidence support the notion that hemides- 
mosomes mediate stable adhesion to the basement mem- 
brane (Uitto and Christiano, 1992; Guo et al., 1995; Spinardi 
et al.,  1995).  Their disruption may therefore result in  a 
more dynamic interaction with the extracellular matrix. In 
accordance with  this hypothesis, we  have observed that 
the disassembly of hemidesmosomes caused by EGF cor- 
relates with an increase in ot6[34-dependent  cell migration. 
This observation suggests that the ability of Ot6134 to medi- 
ate cell migration on laminins can be upregulated by fac- 
tors that interfere with its association with the hemidesmo- 
somal cytoskeleton. It is well known that EGF and TGF-et 
can promote the reepithelialization of wounds (Schultz et 
al., 1991), and it has recently been observed that kerati- 
nocytes lose their hemidesmosomes as they migrate into 
corneal wounds (Gipson et al., 1993). Thus, the ability of 
activated EGFR to coordinately disassemble hemidesmo- 
somes and increase cell migration on laminins is likely to 
be important during wound healing. In addition, there is 
evidence indicating that keratinocytes of patients affected 
by the skin disease psoriasis overproduce TGF-ot (Elder et 
al.,  1989)  and that squamous carcinoma cells overexpress 
the EGFR (Yamamoto et al.,  1986; Ozanne et al.,  1986). 
In both pathological situations, the expression of 0t6134 is no 
longer restricted to the  basal  surface of those cells that 
abut the basement  membrane,  but  extends suprabasally 
(Kimmel and Carey, 1986; Pellegrini et al., 1992). Our cur- 
rent results suggest that the loss of e%[34 polarity observed 
in these diseases may result from the ability of activated 
EGFR to disrupt  the  association  of the  integrin  to the 
hemidesmosomal cytoskeleton. They further suggest that 
the ability of EGFR to affect the association of ~6134 with 
the cytoskeleton may contribute to the invasive ability of 
squamous carcinoma cells. 
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